BioSpace News Archive

Policy

FTC Lawsuit Holds Up IQVIA’s Advertising Acquisition of Propel Media

The Federal Trade Commission’s increased scrutiny of mergers has now hit IQVIA, whose proposed acquisition of Propel Media has been challenged by the watchdog agency.

July 26, 2023
·
2 min read
·
Tristan Manalac
Business

GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot

While GlaxoSmithKline is anticipating a slower uptake of respiratory syncytial virus vaccine Arexvy, CEO Emma Walmsley said Wednesday the company is pinning much of its growth on the vaccine’s performance.

July 26, 2023
·
2 min read
·
Tristan Manalac
Job Trends

The 9 US States with the Best Job Markets Hiring Now

In a recent study of the U.S. states with the best and worst job markets, nine came out on top. Read on for details about the life sciences industry and jobs available in each state.

July 26, 2023
·
4 min read
·
Rosemary Scott
Policy

UK Probes Weight Loss, Diabetes Drugs for Suicidal Ideation and Self-Harm Risk

On the heels of a European Union investigation, the UK’s health agency is reviewing safety data for GLP-1 receptor agonists after reports of self-harm and suicidal thoughts.

July 26, 2023
·
2 min read
·
Connor Lynch
Business

FibroGen CEO Resigns Amid Clinical Losing Streak, Layoffs

Following several clinical failures for its candidates Roxadustat and pamrevlumab, FibroGen CEO Enrique Conterno is stepping down for “personal reasons,” the company announced Tuesday.

July 26, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Merck, Moderna Launch Pivotal Cancer Vaccine Trial for High-Risk Melanoma

The Phase III trial, which will test the companies’ mRNA-based personalized cancer vaccine and Merck’s blockbuster Keytruda checkpoint inhibitor, is slated for completion by the fall of 2029.

July 26, 2023
·
2 min read
·
Kate Goodwin
Bio NC

Verona Pharma to Present at 43rd Annual Canaccord Growth Conference

Verona Pharma plc announces that senior management will present a company overview at the 43rd Annual Canaccord Growth Conference on Wednesday, August 9, 2023 at 12:00 PM EDT / 5:00 PM BST.

July 26, 2023
·
2 min read
Business

NeoImmuneTech Welcomes Two New Members to its Scientific Advisory Board

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announces the addition of two distinguished experts to its Scientific Advisory Board.

July 26, 2023
·
5 min read
ALSA Ventures launches Vantage Biosciences to treat Diabetic Eye Disease

Vantage Biosciences, a new company launched by ALSA Ventures which invests in novel therapeutics for unmet medical needs, is pleased to announce the acquisition of lead asset VX-01, an oral therapy targeting diabetic eye diseases, set to enter Phase 2 clinical development in mid-2024.

July 26, 2023
·
3 min read
Business

Myolex Appoints Healthcare Entrepreneur Dave Dickinson as Chief Executive Officer

Myolex® Inc. announced that Dave Dickinson has been named the company’s Chief Executive Officer and Board Director.

July 26, 2023
·
2 min read